MALERBA MEDICA: what changed
MALERBA MEDICA
Largest movements
- Receivables within one year +€267,927
up €267,927 (+243%), from €110,385 to €378,312
of which Other amounts receivable: +€269,579
- Cash +€145,890
up €145,890 (+56.5%), from €258,053 to €403,943
mainly Net result for the year (+€311,857) and Tax, wage and social debts (+€102,373)
- Profit (loss) carried forward +€311,857
up €311,857 (+111%), from €280,940 to €592,797
- Tax, wage and social debts +€102,373
up €102,373 (+113%), from €90,535 to €192,908
- Gross operating margin +€54,850
up €54,850 (+15.2%), from €361,997 to €416,848
- Taxes +€15,834
up €15,834 (+17.9%), from €88,537 to €104,371
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €372,992 | €793,041 | +€420,049 | +113% |
| Fixed assets | 21/28 | €1,581 | €5,250 | +€3,669 | +232% |
| Tangible fixed assets | 22/27 | - | €3,669 | +€3,669 | |
| Furniture and vehicles | 24 | - | €3,669 | +€3,669 | |
| Financial fixed assets | 28 | €1,581 | €1,581 | = | 0.0% |
| Current assets | 29/58 | €371,411 | €787,792 | +€416,381 | +112% |
| Amounts receivable within one year | 40/41 | €110,385 | €378,312 | +€267,927 | +243% |
| Trade receivables | 40 | €93,817 | €92,166 | -€1,652 | -1.8% |
| Other amounts receivable | 41 | €16,567 | €286,146 | +€269,579 | +1,627% |
| Cash at bank and in hand | 54/58 | €258,053 | €403,943 | +€145,890 | +56.5% |
| Deferred charges and accrued income | 490/1 | €2,973 | €5,537 | +€2,564 | +86.2% |
| Total equity and liabilities | 10/49 | €372,992 | €793,041 | +€420,049 | +113% |
| Equity | 10/15 | €281,940 | €593,797 | +€311,857 | +111% |
| Contributions | 10/11 | €1,000 | €1,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €280,940 | €592,797 | +€311,857 | +111% |
| Amounts payable | 17/49 | €91,053 | €199,245 | +€108,192 | +119% |
| Amounts payable within one year | 42/48 | €91,053 | €199,245 | +€108,192 | +119% |
| Trade debts | 44 | €517 | €6,337 | +€5,819 | +1,125% |
| Suppliers | 440/4 | €517 | €6,337 | +€5,819 | +1,125% |
| Taxes, remuneration and social security | 45 | €90,535 | €192,908 | +€102,373 | +113% |
| Taxes | 450/3 | €90,535 | €192,908 | +€102,373 | +113% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €559 | +€559 | |
| Other operating charges | 640/8 | €420 | - | -€420 | |
| Gross operating margin | 9900 | €361,997 | €416,848 | +€54,850 | +15.2% |
| Operating profit (loss) | 9901 | €361,578 | €416,288 | +€54,711 | +15.1% |
| Financial charges | 65/66B | €95 | €60 | -€34 | -36.2% |
| Recurring financial charges | 65 | €95 | €60 | -€34 | -36.2% |
| Profit (loss) for the period before taxes | 9903 | €361,483 | €416,228 | +€54,745 | +15.1% |
| Income taxes | 67/77 | €88,537 | €104,371 | +€15,834 | +17.9% |
| Profit (loss) for the period | 9904 | €272,946 | €311,857 | +€38,911 | +14.3% |
| Profit (loss) for the period to be appropriated | 9905 | €272,946 | €311,857 | +€38,911 | +14.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 8 November 2026 via checked.be.